- Home
- PNR vs ZBH Comparison
PNR vs ZBH Comparison
Compare PNR & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PNR | ZBH |
|---|---|---|
| Founded | 1966 | 1927 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1B | 19.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PNR | ZBH |
|---|---|---|
| Price | $104.32 | $94.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 19 |
| Target Price | ★ $118.23 | $108.56 |
| AVG Volume (30 Days) | 1.2M | ★ 2.1M |
| Earning Date | 10-21-2025 | 11-05-2025 |
| Dividend Yield | 0.96% | ★ 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | 3.93 | ★ 4.03 |
| Revenue | $4,128,399,999.00 | ★ $8,010,900,000.00 |
| Revenue This Year | $2.97 | $8.20 |
| Revenue Next Year | $4.64 | $5.92 |
| P/E Ratio | $26.53 | ★ $23.38 |
| Revenue Growth | 0.83 | ★ 5.47 |
| 52 Week Low | $74.25 | $85.33 |
| 52 Week High | $113.95 | $114.44 |
Technical Indicators
Market Signals| Indicator | PNR | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 43.79 | 49.85 |
| Support Level | $103.78 | $92.14 |
| Resistance Level | $106.68 | $98.34 |
| Average True Range (ATR) | 2.21 | 1.99 |
| MACD | 0.19 | 0.49 |
| Stochastic Oscillator | 55.46 | 58.27 |
Price Performance
Historical ComparisonAbout PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.1 billion in revenue in 2024.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.